Skip to main content
. 2003 May 17;326(7398):1083–1084. doi: 10.1136/bmj.326.7398.1083

Figure 1.

Figure 1

Percentage changes in bone mineral density among women treated with alendronate or raloxifene after 12 and 24 months, showing regression to the mean at 24 months. Women are grouped according to the percentage change at 12 months, and values for 24 months are percentage change from value at 12 months